Gabriella's Shared Resources
Modern Antiviral Treatments for HCV Achieve More Than 98% Cure Rates
Decades ago, in the 1970s, cases of transfusion-associated hepatitis, called non-A, non-B hepatitis (NANBH), were often chronic, but the cause...
UK’s 2030 Hepatitis Elimination Strategy
Hepatitis B and C viruses remain leading causes of disability and premature death worldwide. In May 2016, the UK adopted...
Direct-Acting Antivirals Achieve High Cure Rates
Hepatitis C virus (HCV) is a significant public health issue, with an increasing seroprevalence of anti-HCV antibodies from 2.3% to...
Hepatitis C: Rising Infections and Effective Treatments Highlight Need for Screening and Prevention
Hepatitis C is a liver infection caused by the hepatitis C virus (HCV), which can lead to cirrhosis, liver cancer,...
Cost-Effectiveness Analysis for Hepatitis C Treatment
Are direct-acting antivirals for the treatment of hepatitis C virus (HCV) more effective than peginterferon alfa and ribavirin (PEG/riba)? Researchers...
NHANES Data Show 2 Million US HCV Cases: Calls for Improved Testing and Treatment
A study using 2013-2016 National Health and Nutrition Examination Survey (NHANES) data to update hepatitis C virus (HCV) infection prevalence...
